Work

Final report of an open-label phase II trial of bevacizumab plus docetaxel and gemcitabine in metastatic, previously untreated nonsquamous non-small cell lung cancer (NSCLC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e18046

Authors: Nathan A. Pennell, Sujith R. Kalmadi, Marc A. Shapiro, Hamed Daw, Cristina P. Rodriguez, Abdo S. Haddad, Tara Rich, Julia Samsa, Paul Elson, Patrick C. Ma, Afshin Dowlati

Institutions: Cleveland Clinic, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604495782

Cites:

Cited by:

Related to: 10